Optimizing target coverage by dosimetric feedback during prostate brachytherapy

被引:31
作者
Cormack, RA
Tempany, CM
D'Amico, AV
机构
[1] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2000年 / 48卷 / 04期
关键词
brachytherapy; magnetic resonance; dosimetry; prostate cancer;
D O I
10.1016/S0360-3016(00)00742-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Postimplant dosimetry of permanent prostate implants shows a loss of coverage compared to the preplan,One contributing factor is needle misplacement. The significance of needle misplacement and the clinical utility of dosimetric feedback mere analyzed in the setting of interventional magnetic resonance (IMR) guided prostate brachytherapy. Methods and Materials: Information provided by an intraoperative planning system was analyzed for 10 patients. Needle misplacement was measured and the dosimetric consequences calculated. Additional catheters and sources were placed following the insertion of all planned catheters to compensate for nonideal needle placement. Results: Source misplacement ranged from 0.0 to 1.0 cm (median, 0.3 cm). The resulting loss of coverage ranged from 1% to 13%, and the intraoperative dosimetric feedback allowed a recovery of from 0% to 12% coverage. Between 0 and 3 (median, 2) additional needles and from 0 to 10 (median, 8) additional sources were required to restore coverage of the target, Final planned coverage exceeded 94% for all patients. Conclusion: The discrepancy between planned and achieved needle placement leads to a loss of dosimetric coverage of the target volume. Dosimetric feedback allows compensation for needle divergence. The technique of real-time dosimetric feedback does not require an IR-IR system, and could be generalized to ultrasound-guided implants, (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1245 / 1249
页数:5
相关论文
共 15 条
  • [1] [Anonymous], 1987, ENDOCURIETHER HYPERT
  • [2] Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy
    Bice, WS
    Prestidge, BR
    Grimm, PD
    Friedland, JL
    Feygelman, V
    Roach, M
    Prete, JL
    Dubois, DF
    Blasko, JC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (04): : 921 - 927
  • [3] A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging
    Cormack, RA
    Kooy, H
    Tempany, CM
    D'Amico, AV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (01): : 207 - 214
  • [4] CORMACK RA, 1997, P 12 INT C US COMP R, V1, P124
  • [5] Defining the implant treatment volume for patients with low risk prostate cancer: Does the anterior base need to be treated?
    D'Amico, AV
    Davis, A
    Vargas, SO
    Renshaw, AA
    Jiroutek, M
    Richie, JP
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (03): : 587 - 590
  • [6] Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer
    D'Amico, AV
    Cormack, R
    Tempany, CM
    Kumar, S
    Topulos, G
    Kooy, HM
    Coleman, CN
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (03): : 507 - 515
  • [7] TRANSPERINEAL I125 SEED IMPLANTATION IN PROSTATIC-CANCER GUIDED BY TRANS-RECTAL ULTRASONOGRAPHY
    HOLM, HH
    JUUL, N
    PEDERSEN, JF
    HANSEN, H
    STROYER, I
    [J]. JOURNAL OF UROLOGY, 1983, 130 (02) : 283 - 286
  • [8] Image-guided procedures and the operating room of the future
    Jolesz, FA
    [J]. RADIOLOGY, 1997, 204 (03) : 601 - 612
  • [9] KOOY HM, 1998, ASTRO 1998 ANN M PHO
  • [10] Ladd ME, 1998, MED RAD DIA IMG, P35